Company Profile For Merck & Co., Inc.

Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of products to improve human and animal health. The Company’s operations are principally managed on a products basis and consist of two business segments. The Pharmaceutical segment includes human health pharmaceutical products marketed either directly or through joint ventures. These products consist of therapeutic and preventive agents, sold by prescription, for the treatment of human disorders. The Vaccines and Infectious Diseases segment includes human health vaccine products marketed either directly or through a joint venture. These products consist of preventative pediatric, adolescent and adult vaccines, primarily administered at physician offices. Infectious disease products consist of therapeutic agents for the treatment of infection sold primarily to drug wholesalers and retailers, hospitals and government agencies.

BRIEF: For the nine months ended 30 September 2009, Merck & Co., Inc.'s revenues fell 3% to $17.33B. Net income applicto common rose 4% to $6.39B. Revenues reflect a decrease in the demand of Pharmaceutical segment and lower Vaccines & Infectious Diseases segments. Net income was offset by a decrease in marketing & administrative expense, lower restructuring costs, an increase in equity income from affiliates and a rise in other (income) expense.